Symbol="CRVS"
AssetType="Common Stock"
Name="Corvus Pharmaceuticals Inc"
Description="Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. The company is headquartered in Burlingame, California."
CIK="1626971"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="863 MITTEN ROAD, SUITE 102, BURLINGAME, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="101054000"
EBITDA="-29703000"
PERatio="None"
PEGRatio="0"
BookValue="1.012"
DividendPerShare="0"
DividendYield="0"
EPS="-0.78"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.249"
ReturnOnEquityTTM="-0.601"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.576"
EVToRevenue="-"
EVToEBITDA="0.265"
Beta="0.975"
num_52WeekHigh="4.19"
num_52WeekLow="0.607"
num_50DayMovingAverage="2.58"
num_200DayMovingAverage="1.444"
SharesOutstanding="46568500"
DividendDate="None"
ExDividendDate="None"
symbol="CRVS"
open="2.21"
high="2.26"
low="2.14"
price="2.23"
volume="115588.00"
latest_trading_day="2023-08-14"
previous_close="2.24"
change="-0.01"
change_percent="-0.4464%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="11"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="89"
Volume_recent_avg="828787"
Change_recent_avg="0.01"
Delta_recent_avg="0.25"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="0.11"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="89"
Aroon_momentum_negative="11"
image_negative_thumbnail_id_1="1152"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0185.jpeg"
image_negative_thumbnail_id_2="495"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0110.jpeg"
image_neutral_thumbnail_id_1="591"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_neutral_thumbnail_id_2="581"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_positive_thumbnail_id_1="658"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0050.jpeg"
image_positive_thumbnail_id_2="627"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0081.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
